1 / 11

NECN Lung NSSG Audit of Waiting Times for Lung Cancer Patients in NECN April 2010 – March 2011

NECN Lung NSSG Audit of Waiting Times for Lung Cancer Patients in NECN April 2010 – March 2011. The scope of the audit :.

dyre
Download Presentation

NECN Lung NSSG Audit of Waiting Times for Lung Cancer Patients in NECN April 2010 – March 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NECN Lung NSSGAudit of Waiting Times for Lung Cancer Patients in NECNApril 2010 – March 2011

  2. The scope of the audit : • The purpose of this audit was to determine how long patients wait for each part of the patient pathway from referral to treatment in NECN and to assess the degree of variation between different trusts in the Network.

  3. Key Findings • A total of 3,386 2WW referrals seen in trusts in NECN during 2010/11 • A total of 28,570 wait days; an average wait of 8.4 days across NECN per referral • 2,488 First Treatments • 1,085 (43.6%) patients treated following urgent referral • 53,607 wait days – average 49 days

  4. Source: CWT Database Open Exeter

  5. Source: CWT Database Open Exeter

  6. Source: CWT Database Open Exeter

  7. Source: CWT Database Open Exeter

  8. Source: CWT Database Open Exeter

  9. Source: CWT Database Open Exeter

  10. Conclusion • Average waits in all trusts are below the maximum waits stipulated in cancer waiting times targets • This analysis shows apparent variation in average waits between individual trusts, although no account is taken of casemix and therefore real variation cannot be confirmed.

  11. Recommendations • The Lung NSSG should consider the results of this audit and agree actions and further analysis as necessary • Further analyses should be carried out to provide further detail on apparent variation between trusts in the diagnostic phase of the pathway • Regular audit of this activity to measure ongoing impact of interventions

More Related